Z-1183-2021 Class III Terminated
FDA device recall Z-1183-2021 was initiated by OraSure Technologies, Inc. on Feb 5, 2021 and is designated Class III. Reason for recall: Incorrect lot of Substrate Reagent (TMB) may be included in the kit. The original kit box labeling and the specification sheet listed the Substrate Reagent (TMB) lot 6676239, but contained Substrate… The recall status is terminated (terminated Mar 30, 2023). Affected quantity: 16 units.
Recall details
- Product Type
- Devices
- Report Date
- Mar 17, 2021
- Initiation Date
- Feb 5, 2021
- Termination Date
- Mar 30, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16 units
Product description
Methamphetamine Intercept Microplate kit EIA - IVD qualitative determination of methamphetamine in oral fluid, PN 11041C.
Reason for recall
Incorrect lot of Substrate Reagent (TMB) may be included in the kit. The original kit box labeling and the specification sheet listed the Substrate Reagent (TMB) lot 6676239, but contained Substrate Reagent (TMB) lot 6679623, should not affect performance.
Distribution pattern
US Nationwide distribution in the states of KS, NJ, OH, VA.
Code information
Lot 6681090, Exp date 2021-03. UDI: 608337000191
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1183-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026